Validation of the capacity of SKL in bloodstream to cross BBB and its therapeutic use in neurodegenerative and demyelinating diseases

  • Chillón Rodriguez, Miguel (Principal Investigator)
  • Espinosa Parrilla, Juan Francisco (Investigator)
  • Puig Ferrer, Meritxell (Investigator)

Project Details

StatusFinished
Effective start/end date3/10/1726/02/18

Funding

  • Agència de Gestió d'Ajuts Universitaris i de Recerca: €20,000.00